Did Oshida et al. show that there is massive risk of intracranial aneurysm rupture within days after receiving mRNA technology based COVID gene injections-vaccination? Yes! 3 cases as an examples
by Paul Alexander
of ruptured brain aneurysms (Subarachnoid hemorrhage); aneurysmal subarachnoid hemorrhage (SAH) risk with COVID mRNA technology based shots (Kariko, Weissman et al.'s invention); Japan
SOURCE:
https://pubmed.ncbi.nlm.nih.gov/35509565/
Background: ‘the incidence and details of three patients who presented with intracranial aneurysm rupture shortly after receiving mRNA COVID-19 vaccines…
retrospectively reviewed the medical records of individuals who received a first and/ or second dose of mRNA COVID-19 vaccine between March 6, 2021, and June 14, 2021, in a rural district in Japan, and identified the occurrences of aneurysmal SAH within 3 days after mRNA vaccination…
assessed incidence rates (IRs) for aneurysmal SAH within 3 days after vaccination and spontaneous SAH for March 6-June 14, 2021, and for the March 6-June 14 intervals of a 5-year reference period of 2013-2017. We assessed the incidence rate ratio (IRR) of aneurysmal SAH within 3 days after vaccination and spontaneous SAH compared to the crude incidence in the reference period (2013-2017)…
Among 34,475 individuals vaccinated during the study period, three women presented with aneurysmal SAH (IR: 1058.7/100,000 person-years), compared with 83 SAHs during the reference period (IR: 20.7/100,000 persons-years). IRR was 0.026 (95% confidence interval [CI] 0.0087-0.12; P < 0.001). A total of 28 spontaneous SAHs were verified from the Iwate Stroke Registry database during the same period in 2021 (IR: 34.9/100,000 person-years), and comparison with the reference period showed an IRR of 0.78 (95%CI 0.53-1.18; P = 0.204)…
All three cases developed SAH within 3 days (range, 0-3 days) of the first or second dose of BNT162b2 mRNA COVID-19 vaccine by Pfizer/BioNTech. The median age at the time of SAH onset was 63.7 years (range, 44- 75 years). Observed locations of ruptured aneurysms in patients were the bifurcations of the middle cerebral artery, internal carotid-posterior communicating artery, and anterior communicating artery, respectively…
pharmacovigilance must be maintained to monitor potentially fatal adverse events and identify possible associations.’
Computed tomography (CT) shows subarachnoid hemorrhage (upper, left) and left Sylvian hematoma (upper, right). Preoperative CT angiography demonstrates a saccular aneurysm (white arrow) (lower, left). Intraoperative images of post clip ligation indicating rupture of the aneurysm (white arrow) (lower, right).
Computed tomography demonstrates subarachnoid hemorrhage (upper). Oblique view of the left carotid injection shows internal carotid-posterior communicating artery aneurysm with a daughter sac (white arrow) (lower, left). Postoperative angiography reveals complete obliteration of the aneurysm (white arrow) (lower, right).
Computed tomography (CT) (upper, left) and magnetic resonance imaging (upper, right) demonstrate subarachnoid hemorrhage (white and black arrows). Aneurysms were confirmed by CT angiography (white and black arrowhead) (lower, left) and were confirmed as the bleeding source intraoperatively (white arrow) (lower, right).